Učitavanje...
Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury
Sepsis-associated acute kidney injury (SA-AKI) is associated with high mortality rates, but clinicians lack effective treatments except supportive care or renal replacement therapies. Recently, histone deacetylase (HDAC) inhibitors have been recognized as potential treatments for acute kidney injury...
Spremljeno u:
| Izdano u: | Am J Physiol Renal Physiol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Physiological Society
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792695/ https://ncbi.nlm.nih.gov/pubmed/33017186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00405.2020 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|